Global Point of Care (POC) Hematology and Flow Cytometry Market, By Product Type (Flow Cytometry Instruments, Reagent and Consumables, Accessories), Technology (Bead-Based Flow Cytometry, Cell-Based Flow Cytometry), End User (Biotechnology and Pharmaceutical Companies, Hospitals, Clinics, Research Centers, Clinical Testing Laboratories, Academics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Point of Care (POC) Hematology and Flow Cytometry
Point of care (POC) hematology and flow cytometry market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 4920.92 million by 2028 and will grow at a CAGR of 7.86% in the above mentioned forecast period.
Hematology is a subdivision or a branch of medicine that involves the study and treatment of blood. While, the flow cytometry examines the whole blood component and is a laser-based biophysical technology which is involved in the cell counting, cell sorting, protein detection and biomarker detection.
The high adoption of flow cytometry techniques in research and academia is amongst the important factor expected to intensify the growth and demand of point of care (POC) hematology and flow cytometry market. In addition, the rise in the geriatric population and increase in investments by government bodies to improve healthcare facilities are also expected contributes to the growth in the global market over the forecast period of 2021 to 2028. Also the high adoption of technologically advanced products and the rise in the public-private initiatives in the field of immunology and immuno-oncology research are also likely to enhance the growth of the market. Furthermore, the rapid technological advancements and increased availability of application-specific products are also amongst the significant factors expected to fuel the growth of the point of care (POC) hematology and flow cytometry market.
The high adoption of recombinant DNA technology for antibody production, rise in the pipeline for stem cell research and rapid evolution of tandem flow cytometry technologies are anticipated to offer significant growth opportunities for the point of care (POC) hematology and flow cytometry market in the forecast period of 2021 to 2028.
However, the limited purchasing power of end users and high product costs are expected to curb the growth of the point of care (POC) hematology and flow cytometry market, whereas the availability of cheaper and better substitutes for flow cytometry can challenge the growth of the point of care (POC) hematology and flow cytometry market.
This point of care (POC) hematology and flow cytometry market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on point of care (POC) hematology and flow cytometry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Point of Care (POC) Hematology and Flow Cytometry Market Scope and Market Size
Point of care (POC) hematology and flow cytometry market is segmented on the basis of product type, technology and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the point of care (POC) hematology and flow cytometry market is segmented into flow cytometry instruments, reagent and consumables and accessories. Flow cytometry instruments have further been segmented into cell analyzers and cell sorters.
- The technology segment of the point of care (POC) hematology and flow cytometry market is segmented into bead-based flow cytometry and cell-based flow cytometry.
- On the basis of end user, the point of care (POC) hematology and flow cytometry market is segmented into biotechnology and pharmaceutical companies, hospitals, clinics, research centers, clinical testing laboratories, academics and others.
Point of Care (POC) Hematology and Flow Cytometry Market Country Level Analysis
Point of care (POC) hematology and flow cytometry market is analyzed and market size insights and trends are provided by country, product type, technology and end user as referenced above.
The countries covered in the point of care (POC) hematology and flow cytometry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the point of care (POC) hematology and flow cytometry market owing to the increase in the demand for improved efficiency and rise in the government initiatives. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the high growth in the pharmaceutical and biotechnology industries in the emerging economies such as India and China.
The country section of the point of care (POC) hematology and flow cytometry market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Point of care (POC) hematology and flow cytometry market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care (POC) hematology and flow cytometry market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (POC) hematology and flow cytometry market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Point of Care (POC) Hematology and Flow Cytometry Market Share Analysis
Point of care (POC) hematology and flow cytometry market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to point of care (POC) hematology and flow cytometry market.
The major players covered in the point of care (POC) hematology and flow cytometry market report are Abbott, Agilent Technologies, Thermo Fisher Scientific, Inc., Beckman Coulter, Inc., BD, Bio-Rad Laboratories, Inc., Horiba, Ltd., NIHON KOHDEN CORPORATION, Cardinal Health, Ortho Clinical Diagnostics, F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, Sysmex Europe GmbH, Merck KGaA, Luminex Corporation, Sony Biotechnology Inc., Takara Bio Inc., Enzo Life Sciences, Inc., bioMérieux SA and Cytek Biosciences among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-